R&D channel feed – Endpoints News

R&D channel feed

FDA lifts hold on 4DMT's Fabry gene therapy

9 months ago

Infectious disease biotech undergoes makeover after lung disease trial underwhelms

9 months ago

Aldeyra to resubmit dry eye disease drug this year following positive Phase 3 data

9 months ago

Lilly’s anti-tau pill for Alzheimer’s fails in Phase 2 study

9 months ago

Apellis and Sobi land another late-stage win for rare kidney disease drug

9 months ago

Intellia’s gene editing therapy succeeds in Phase 2 genetic swelling condition study

9 months ago

TIGIT drugs take another hit as Merck stops Phase 3 lung cancer trial for futility

9 months ago

Sanofi’s Sarclisa scores in Phase 3 transplant-eligible multiple myeloma test

9 months ago

FDA grapples with its role in AI, and how to guide industry's adoption

9 months ago

Exelixis’ Cabometyx misses survival endpoint, but will still file in prostate cancer

9 months ago

Updated: Novo Nordisk yanks Wegovy filing for heart failure from FDA, will resubmit next year

9 months ago

Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering

9 months ago

Updated: FDA approves Servier’s brain cancer drug, setting up $1B payout for Agios

9 months ago

Bicycle Therapeutics focuses pipeline and streamlines leadership team

9 months ago

Eisai picks SEED Therapeutics for molecular glue deal worth as much as $1.5B

9 months ago

Genentech partners with cash-strapped Sangamo on epigenetic Alzheimer’s therapy

9 months ago

A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals

9 months ago

Ultimovacs’ cancer vaccine flunks again — this time in head and neck cancer

9 months ago

BioMarin scales back launch for hemophilia gene therapy, pitches path to profitability

9 months ago

Eliot Forster’s pain biotech unveils Phase 2 data in degenerative joint disease

9 months ago

Nuvation pauses BET inhibitor plans after checking out interim Phase 1 data

9 months ago

Q&A: Genentech's new CEO on AI, IRA and radiopharma

9 months ago

FDA wants new trial of Actinium’s radioactive iodine drug, company to seek partner

9 months ago

Bayer plans label expansion for Kerendia after Phase 3 win in heart failure

9 months ago

First page Previous page 30 31 323334 35 36 Next page Last page